Benzinga's Top #PreMarket Losers

AMAG Pharmaceuticals

shares fell 16% to $18.38 in the pre-market trading after the company received a CRL from the FDA for the supplemental NDA for Feraheme for broader IDA indication. Coach

dipped 5.86% to $49.47 in the pre-market session after the company reported downbeat fiscal second-quarter profit. International Business Machines

shares dropped 3.35% to $182.11 in pre-market trading after the company reported downbeat fourth-quarter revenue and issued weak full-year earnings forecast. Xilinx

dipped 3.03% to $46.10 after the company issued a weak current-quarter revenue outlook.